Prostate cancer screening--time to abandon one-size-fits-all approach?

JAMA. 2011 Dec 28;306(24):2717-8. doi: 10.1001/jama.2011.1881.
No abstract available

MeSH terms

  • Advisory Committees
  • Aged
  • Genomics / trends
  • Guidelines as Topic
  • Health Policy
  • Humans
  • Insurance Coverage
  • Life Expectancy
  • Male
  • Mass Screening / economics
  • Mass Screening / standards*
  • Middle Aged
  • Patient Preference*
  • Population Dynamics
  • Prognosis
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / blood*
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / pathology
  • Proteomics / trends
  • Randomized Controlled Trials as Topic
  • Risk
  • Risk Assessment
  • United States
  • Unnecessary Procedures

Substances

  • Prostate-Specific Antigen